G. Vandermeulen

发表

PLGA based drug delivery systems: Promising carriers for wound healing activity

K. K. Chereddy, G. Vandermeulen, V. Préat, 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery.

G. Vandermeulen, V. Préat, L. Plapied, 2010, International journal of pharmaceutics.

Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.

Kevin Vanvarenberg, Caroline Bouzin, Héloïse Ragelle, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Clinical potential of electroporation for gene therapy and DNA vaccine delivery

Laure Lambricht, Gregor Sersa, Gaëlle Vandermeulen, 2016, Expert opinion on drug delivery.

PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing.

K. K. Chereddy, G. Vandermeulen, V. Préat, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Polymer-Based Nanoparticles as Modern Vaccine Delivery Systems

G. Vandermeulen, V. Préat, Laure Lambricht, 2017 .

Chitosan Nanoparticles for SiRNA Delivery In Vitro.

G. Vandermeulen, V. Préat, H. Ragelle, 2016, Methods in molecular biology.

Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds.

P. Carmeliet, K. K. Chereddy, G. Vandermeulen, 2015, Nanomedicine : nanotechnology, biology, and medicine.

Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer.

G. Dickson, G. Vandermeulen, V. Préat, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Combined effect of PLGA and curcumin on wound healing activity.

K. K. Chereddy, G. Vandermeulen, V. Préat, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles.

M. Brewster, G. Vandermeulen, V. Préat, 2006, International journal of pharmaceutics.

Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach.

Liana C. Silva, V. Oliveira, G. Vandermeulen, 2014, Nanomedicine.

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine

V. Cerullo, S. Pesonen, G. Vandermeulen, 2022, Frontiers in Immunology.

New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2021, Journal for ImmunoTherapy of Cancer.

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2022, Pharmaceutics.

Pharmaceutical Nanotechnology Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(-caprolactone-co-trimethylenecarbonate) polymeric micelles

G. Vandermeulen, A. Arien, L. Rouxhet, 2006 .

Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing.

G. Vandermeulen, V. Préat, M. Čemažar, 2017, Bioelectrochemistry.

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin

G. Vandermeulen, V. Préat, L. Prosen, 2016, Molecular therapy. Nucleic acids.

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

V. Cerullo, G. Vandermeulen, V. Préat, 2019, Journal of Immunotherapy for Cancer.

Fibrin hydrogels to deliver dental stem cells of the apical papilla for regenerative medicine.

C. Dupont-Gillain, G. Vandermeulen, V. Préat, 2015, Regenerative medicine.

Effect of Tape Stripping and Adjuvants on Immune Response After Intradermal DNA Electroporation

G. Vandermeulen, V. Préat, B. Ucakar, 2009, Pharmaceutical Research.

Skin-specific promoters for genetic immunisation by DNA electroporation.

D. Scherman, G. Vandermeulen, V. Préat, 2009, Vaccine.

EPR monitoring of wound oxygenation as a biomarker of response to gene therapy encoding hCAP‐18/LL37 peptide

G. Vandermeulen, V. Préat, C. Bouzin, 2018, Magnetic resonance in medicine.

Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma.

G. Vandermeulen, V. Préat, B. Turk, 2015, Molecular therapy. Nucleic acids.

Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy.

O. Feron, C. Dessy, J. Verrax, 2011, Molecular pharmaceutics.

Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.

K. Braeckmans, B. Nysten, G. Vandermeulen, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation

Damijan Miklavcic, Natasa Pavselj, Gaëlle Vandermeulen, 2010, The Journal of Membrane Biology.

Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines.

G. Vandermeulen, V. Préat, J. Grooten, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

G. Vandermeulen, V. Préat, Alessandra Lopes, 2019, Journal of experimental & clinical cancer research : CR.

Ear Pinna : a privileged DNA electroporation site for inducing strong Th1 immune responses

D. Scherman, G. Vandermeulen, V. Préat, 2009 .

Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.

L. Mir, G. Vandermeulen, V. Préat, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.

Robert E. W. Hancock, Gaëlle Vandermeulen, Véronique Préat, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

G. Vandermeulen, V. Préat, Alessandra Lopes, 2019, Journal of Experimental & Clinical Cancer Research.

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2018, Scientific Reports.

APP‐dependent glial cell line‐derived neurotrophic factor gene expression drives neuromuscular junction formation

G. Vandermeulen, J. Loeffler, N. Zanou, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.

C. Uyttenhove, G. Vandermeulen, V. Préat, 2014, Bioelectrochemistry.

Intramuscular electroporation of a P 1 A-encoding plasmid vaccine delays P 815 mastocytoma growth

C. Uyttenhove, G. Vandermeulen, V. Préat, 2014 .

DNA transfer in the skin

G. Vandermeulen, V. Préat, Liévin Daugimont, 2008 .

Use of Staby® technology for development and production of DNA vaccines free of antibiotic resistance gene

H. Nauwynck, G. Vandermeulen, V. Préat, 2013, Human vaccines & immunotherapeutics.

Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivo

D. Scherman, M. Bureau, M. Rols, 2010, The journal of gene medicine.

In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.

Mafalda Videira, Gaëlle Vandermeulen, Véronique Préat, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Chitosan-based siRNA delivery systems.

Héloïse Ragelle, Gaëlle Vandermeulen, Véronique Préat, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Optimisation of intradermal DNA electrotransfer for immunisation.

Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2017, Molecular therapy. Nucleic acids.

pFARs, Plasmids free of antibiotic resistance markers, display high‐level transgene expression in muscle, skin and tumour cells

D. Scherman, G. Vandermeulen, V. Préat, 2010, The journal of gene medicine.

New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen

L. E. Pedersen, G. Vandermeulen, V. Préat, 2015, PloS one.

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin.

Simona Kranjc, Gregor Sersa, Gaëlle Vandermeulen, 2016, Molecular therapy. Nucleic acids.

Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma

G. Vandermeulen, V. Préat, M. Čemažar, 2019, PloS one.

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2018, Scientific Reports.

Chitosan-based siRNA delivery systems.

G. Vandermeulen, V. Préat, Héloïse Ragelle, 2013, Journal of controlled release : official journal of the Controlled Release Society.

pFAR plasmids: New Eukaryotic Expression Vectors for Gene Therapy, devoid of Antibiotic Resistance Markers

D. Scherman, G. Vandermeulen, V. Préat, 2008 .